Tumor-Specific Isoform Switch of the Fibroblast Growth Factor Receptor 2 Underlies the Mesenchymal and Malignant Phenotypes of Clear Cell Renal Cell CarcinomasQI ZHAO; CABALLERO, Otavia L; DAVIS, Ian D et al.Clinical cancer research (Print). 2013, Vol 19, Num 9, pp 2460-2472, issn 1078-0432, 13 p.Article

Immunoediting and persistence of antigen-specific immunity in patients who have previously been vaccinated with NY-ESO-1 protein formulated in ISCOMATRIX™NICHOLAOU, Theo; WEISAN CHEN; MARASKOVSKY, Eugene et al.Cancer immunology and immunotherapy. 2011, Vol 60, Num 11, pp 1625-1637, issn 0340-7004, 13 p.Article

Efficacy and Safety of Pazopanib in Patients With Metastatic Renal Cell CarcinomaHUTSON, Thomas E; DAVIS, Ian D; PANDITE, Lini et al.Journal of clinical oncology. 2010, Vol 28, Num 3, pp 475-480, issn 0732-183X, 6 p.Article

Pazopanib in Locally Advanced or Metastatic Renal Cell Carcinoma: Results of a Randomized Phase III TrialSTERNBERG, Cora N; DAVIS, Ian D; ZARBA, Juan J et al.Journal of clinical oncology. 2010, Vol 28, Num 6, pp 1061-1068, issn 0732-183X, 8 p.Article

A phase I biodistribution and pharmacokinetic trial of humanized monoclonal antibody Hu3s193 in patients with advanced epithelial cancers that express the lewis-Y antigenSCOTT, Andrew M; TEBBUTT, Niall; MACGREGOR, Duncan et al.Clinical cancer research. 2007, Vol 13, Num 11, pp 3286-3292, issn 1078-0432, 7 p.Article

A phase 1 and pharmacokinetic study of gemcitabine and oxaliplatin in patients with solid tumorsGAN, Hui K; MITCHELL, Paul L; GALETTIS, Peter et al.Cancer chemotherapy and pharmacology. 2006, Vol 58, Num 2, pp 157-164, issn 0344-5704, 8 p.Article

Intravesical chemotherapy plus bacille Calmette-Guerin in non-muscle invasive bladder cancer: a systematic review with meta-analysis : Urological OncologyHOUGHTON, Baerin B; CHALASANI, Venu; HAYNE, Dickon et al.BJU international (Papier). 2013, Vol 111, Num 6, pp 977-983, issn 1464-4096, 7 p.Article

Prostate cancer immunology ― an update for UrologistsRAJARUBENDRA, Nieroshan; LAWRENTSCHUK, Nathan; BOLTON, Damien M et al.BJU international (Papier). 2011, Vol 107, Num 7, pp 1046-1051, issn 1464-4096, 6 p.Article

Regulatory T-Cell - Mediated Attenuation of T-Cell Responses to the NY-ESO-1 ISCOMATRIX Vaccine in Patients with Advanced Malignant MelanomaNICHOLAOU, Theo; EBERT, Lisa M; LINDA PAN et al.Clinical cancer research (Print). 2009, Vol 15, Num 6, pp 2166-2173, issn 1078-0432, 8 p.Article

IL-21 induces in vivo immune activation of NK cells and CD8⁺T cells in patients with metastatic melanoma and renal cell carcinomaFREDERIKSEN, Klaus Stensgaard; LUNDSGAARD, Dorthe; SKAK, Kresten et al.Cancer immunology and immunotherapy. 2008, Vol 57, Num 10, pp 1439-1449, issn 0340-7004, 11 p.Article

Interleukin-21 Signaling : Functions in Cancer and AutoimmunityDAVIS, Ian D; SKAK, Kresten; SMYTH, Mark J et al.Clinical cancer research. 2007, Vol 13, Num 23, pp 6926-6932, issn 1078-0432, 7 p.Article

Xenografting tumour beneath the renal capsule using modern surgical equipmentLAWRENTSCHUK, Nathan; RIGOPOULOS, Angela; LEE, Fook-Thean et al.European surgical research. 2006, Vol 38, Num 3, pp 340-346, issn 0014-312X, 7 p.Article

Tumor antigen processing and presentation depend critically on dendritic cell type and the mode of antigen deliverySCHNURR, Max; QIYUAN CHEN; VILLADANGOS, Jose et al.Blood. 2005, Vol 105, Num 6, pp 2465-2472, issn 0006-4971, 8 p.Article

Cancer-testis antigen expression in primary cutaneous melanoma has independent prognostic value comparable to that of Breslow thickness, ulceration and mitotic rateSVOBODOVA, Suzanne; BROWNING, Judy; CEBON, Jonathan S et al.European journal of cancer (1990). 2011, Vol 47, Num 3, pp 460-469, issn 0959-8049, 10 p.Article

A Long, Naturally Presented Immunodominant Epitope from NY-ESO-1 Tumor Antigen: Implications for Cancer Vaccine DesignEBERT, Lisa M; YU CHIH LIU; ROSSJOHN, Jamie et al.Cancer research (Chicago, Ill.). 2009, Vol 69, Num 3, pp 1046-1054, issn 0008-5472, 9 p.Article

Tumor antigen expression in melanoma varies according to antigen and stage. CommentaryBARROW, Catherine; BROWNING, Judy; MACGREGOR, Duncan et al.Clinical cancer research. 2006, Vol 12, Num 3, issn 1078-0432, 673-678, 764-771 [14 p.], 1Article

Assessing regional hypoxia in human renal tumours using ¹⁸F-fluoromisonidazole positron emission tomographyLAWRENTSCHUK, Nathan; POON, Aurora M. T; FOO, Serene S et al.BJU international (Papier). 2005, Vol 96, Num 4, pp 540-546, issn 1464-4096, 7 p.Article

Role of adenosine receptors in regulating chemotaxis and cytokine production of plasmacytoid dendritic cellsSCHNURR, Max; TOY, Tracey; SHIN, Amanda et al.Blood. 2004, Vol 103, Num 4, pp 1391-1397, issn 0006-4971, 7 p.Article

Functional comparison of DCs generated in vivo with Flt3 ligand or in vitro from blood monocytes: differential regulation of function by specific classes of physiologic stimuliJEFFORD, Michael; SCHNURR, Max; PARENTE, Phil et al.Blood. 2003, Vol 102, Num 5, pp 1753-1763, issn 0006-4971, 11 p.Article

Specific targeting, biodistribution, and lack of immunogenicity of chimeric anti-GD3 monoclonal antibody KM871 in patients with metastatic melanoma : results of a phase I trialSCOTT, Andrew M; LEE, Fook-Thean; HANAI, Nobuo et al.Journal of clinical oncology. 2001, Vol 19, Num 19, pp 3976-3987, issn 0732-183XArticle

Thyrotoxicosis during sunitinib treatment for renal cell carcinomaGROSSMANN, Mathis; PREMARATNE, Erosha; DESAI, Jayesh et al.Clinical endocrinology (Oxford. Print). 2008, Vol 69, Num 4, pp 669-672, issn 0300-0664, 4 p.Article

Investigation of hypoxia and carbonic anhydrase IX expression in a renal cell carcinoma xenograft model with oxygen tension measurements and 124I-cG250 PET/CTLAWRENTSCHUK, Nathan; LEE, Fook T; JONES, Gareth et al.Urologic oncology. 2011, Vol 29, Num 4, pp 411-420, issn 1078-1439, 10 p.Article

Clinical and Biological Efficacy of Recombinant Human Interleukin-21 in Patients with Stage IV Malignant Melanoma without Prior Treatment: A Phase Ila TrialDAVIS, Ian D; BRADY, Ben; STENSGAARD FREDERIKSEN, Klaus et al.Clinical cancer research (Print). 2009, Vol 15, Num 6, pp 2123-2129, issn 1078-0432, 7 p.Article

Therapeutic Efficacy of¹⁷⁷Lu-CHX-A-DTPA-hu3S193 Radioimmunotherapy in Prostate Cancer Is Enhanced by EGFR Inhibition or Docetaxel ChemotherapyKELLY, Marcus P; SZE TING LEE; LEE, F.-T et al.The Prostate. 2009, Vol 69, Num 1, pp 92-104, issn 0270-4137, 13 p.Article

Predicting Clinical Outcome through Molecular Profiling in Stage III MelanomaJOHN, Thomas; BLACK, Michael A; TORO, Tumi T et al.Clinical cancer research (Print). 2008, Vol 14, Num 16, pp 5173-5180, issn 1078-0432, 8 p.Article